GPR6 in depression
We are investigating GPR6, a receptor on dopamine-signalling neurons, as a novel therapeutic target in depression — using the GPR6-targeting drug CVN424 to probe striatal circuits and behaviour.
We use molecular brain imaging to find new therapeutic targets and biomarkers for psychiatric and neurodegenerative disease — tracking how brain circuits respond to disease and therapy, from rodents to large animals.
We pair PET tracers with MRI, disease models, behaviour, and tissue analysis to connect specific brain targets to function — and to move discoveries toward the clinic.
We are investigating GPR6, a receptor on dopamine-signalling neurons, as a novel therapeutic target in depression — using the GPR6-targeting drug CVN424 to probe striatal circuits and behaviour.
We use SV2A / [¹¹C]UCB-J PET to image synaptic change in disease models and in response to therapies — including deep brain stimulation, exercise, and S-ketamine.
We are developing imaging biomarkers of neuroinflammation across neurodegenerative and psychiatric disease — turning the brain's immune response into a measurable read-out.
Beyond SV2A: dopamine synthesis (FDOPA), metabolism (FDG), and receptor autoradiography.
Rodent, large-animal (Göttingen minipig), and transgenic mouse models of brain disease.
Pairing PET with in vivo and ex vivo MRI (microstructure, diffusion), behaviour, and tissue.
The Landau Lab develops and validates molecular brain imaging to track how neural circuits adapt across disease, injury, and therapy. Working across rodent, large-animal, and genetic models, we combine PET with MRI, behaviour, and tissue analysis.
Our aim is consistent and translational: read-outs that can move from the bench toward the clinic.
We host project students, PhDs, and postdocs who want to work at the interface of imaging, neuroscience, and translation. If our work resonates, we'd love to hear from you.
Get in touch →A selection of recent peer-reviewed publications from the group and its collaborations.
For the full, up-to-date publication list, see Anne M. Landau's profile at Aarhus University ↗.